Impact of diabetes mellitus on angiographic and clinical outcomes after early generation drug-eluting stent implantation

Abstract

A relationship between coronary artery disease and diabetes has been established. Moreover, for patients with coronary artery disease, diabetes has long been considered a poor prognostic factor for percutaneous coronary intervention (PCI) using bare-metal stents or drug-eluting stents (DES). Patients with diabetes have an increased risk of mortality and repeat revascularization compared with nondiabetic patients after PCI. However, the very long-term impact of diabetes after early generation DES is still uncertain. In this study, we evaluate a recent publication, which assessed the angiographic and clinical outcomes of patients with diabetes versus nondiabetic patients after PCI using early generation DES.

Keywords::

• coronary disease
• diabetes
• drug-eluting stent
• percutaneous coronary intervention

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.